Press releases of year 2006
04/10/2006
Novagali Announces Achievement of Targeted Patient Enrolment in Phase III Clinical Trial for Nova22007 in Vernal Keratoconjunctivitis. This pivotal study follows orphan drug designation in Europe.
12/04/2006
Novagali Pharma completes €26 million financing to support phase III clinical trials and development of new ophthalmic products
11/01/2006
Novagali Pharma successfully completes Phase II clinical study with its ophthalmic formulation of Cyclosporine A